(PRWEB UK) 8 April 2013
With many of the world's largest pharmaceutical companies continuing to face the loss of patent protection for key drugs, and with the threat of biosimilar competition looming large, news of breakups, spinoffs and acquisitions fill the headlines.
This new 223 page report The Top 10 Pharma Companies in 2017 provides information about which companies will ride these turbulent waters and stay on top, new and existing products that will drive success, and which drugs are going to see the greatest declines.
No single organisation has all the answers. That’s why this report has combined and distilled extensive analysis from experts in many fields to predict the top 10 Pharma companies in 2017.
Each of the top 10 pharma companies for 2017 has its own report, providing an overall sales forecast, individual sales forecasts for the top 5 drivers and resistors, and a detailed account of the key catalysts that will have an impact on those products, such as forthcoming trial results, new competition, and generic incursion.
View the report: The Top 10 Pharma Companies in 2017
About Report Buyer.
ReportBuyer.com is the independent online store for global business information. The website now lists more than 300,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers.
54 Maltings Place
169 Tower Bridge Road
London, SE1 3LJ
t. +44 (0) 20 7060 7474